Leadership

The COVID-19 pandemic has proven healthcare organizations, even in a crisis, need to tirelessly forge ahead with innovation to be successful. Senior-level healthcare executives need to follow the macro-trends driving the industry forward.

Multiple organizations named announced the appointment of new CEOs, while Acadia Healthcare announced its CEO was retiring in January 2022.

Wellstar announces Le Joyce Naylor in the new diversity, equity and inclusion role; MD Anderson names Caroline Chung, M.D., the first chief data officer; and more executive moves.

More expensive patients and higher expenses as a result of the COVID-19 pandemic will continue to drive hospital and health system losses in 2021.

Mount Sinai has a new president, as does The US Oncology Network; WellSpan appoints its first chief diversity, equity and inclusion officer, Sutter Health’s CEO is retiring in 2022, and more executive moves.

Yale New Haven Health's CEO is retiring after 43 years with the organization, Memorial Sloan Kettering has a new chief nurse executive after two decades and more executive moves and appointments.

Allina Health’s CEO will retire at the end of 2021 while McLaren Bay Region announced a new CEO and the Virginia Commonwealth University Medical Center has a new president. Meanwhile, two interim leaders will fill in at OSU Wexner Medical Center.

Interim executives are made permanent at Cleveland Clinic, Inova Loudoun Hospital, and University of Utah (U of U) Health, while Massachusetts General Hospital (MGH) and MD Anderson announce new hires.

The pandemic caused a jump in healthcare-associated infections in hospitals, highlighting a need to return to infection prevention and control practices that were standard before the pandemic.

Barry Sample, PhD, director of science and technology at Quest Diagnostics, discusses the rise in drug positivity rates among healthcare employees, the reasons behind the rise, and what can be done to combat them.

Tides are changing a year and a half after the COVID-19 onset, as health systems accelerate hiring.

The increase in a more diverse faculty starts with a more diverse group of medical students and residents.

COVID-19 booster shots will become available this fall.

At the HIMSS21 Digital Program, speakers from Highmark Health and Geisinger outlined the ways they are innovating to address chronic disease management and the endurance needed to see it through.

Hospitals with a higher share of Medicare patients performed worse financially and were more likely to face closure or acquisition.

The fifth installment of Turning Points, a Chief Healthcare Executive™ video series in which retiring CEOs reflect on changes they've witnessed throughout their career and discuss the future of healthcare for aspiring healthcare professionals.

Hilary Babcock, MD, MPH, infectious disease specialist at Washington University and BJC Healthcare in St. Louis, Missouri, discusses the COVID-19 vaccine and other vaccine mandates in healthcare settings.

In the fourth installment of the Chief Healthcare Executive™ video series Turning Points, the retiring leader of Alabama's largest academic health system discusses the need for healthcare equity and the mission to improve the health of everyone in the state.

As infections and hospitalizations rise across the country, groups led by the American Medical Association and the American Nurses Association called for mandatory vaccinations of staff.

Third installment of Turning Points, a Chief Healthcare Executive™ video series in which retiring healthcare executives and CEOs reflect on changes they’ve witnessed over the course of their career and discuss the prospective healthcare landscape for future generations.

Shah will bring unique insights into Maven’s 24/7 model that seeks to reduce unnecessary C-sections and emergency department visits and improve clinical outcomes.

Second installment of Turning Points, a Chief Healthcare Executive™ video series that invites retiring hospital and health system CEOs to share insights on how the healthcare landscape has changed and what challenges await the next generation of healthcare leaders.

Peter Urbanowicz, managing director and co-head of Alvarez and Marsal’s Healthcare Industry Group, discusses the FDA’s new focus in addressing supply chain and device shortages posed by the COVID-19 pandemic and what hospitals should be doing in the meantime to adjust.

The transition will occur January 1, 2022.

First installment of a new video series in which retiring health system CEOs reflect on the changing healthcare landscape and the challenges that await the next generation of healthcare leaders.

A few dozen employees had sued but a federal judge dismissed the suit as frivolous.

FCC issues recommendations for stakeholders to combat issue of unlawful robocalls to hospitals, which threaten public health and safety.

Kaveh Safavi, MD, JD, global health lead of Accenture Health, discusses how the pandemic influenced the speed at which healthcare organizations adopted new technologies and how this adoption is impacting patient care.

The wave of post-pandemic retirements continues.